Pal, Sumanta K.
Agarwal, Neeraj
Article History
First Online: 28 June 2016
Competing interests
: S.K.P. receives honoraria from Astellas, Medivation and Novartis, and receives consulting fees from Astellas, Aveo, BMS, Exelixis, Genentech, GSK, Novartis and Pfizer. N.A. declares no competing interests.